Boston Scientific has told the US Securities and Exchange Commission that a cybersecurity incident detected on 25 August has caused “a global disruption to the Company’s operations”, including its ability to process and ship customer orders. Shares fell about 3.5% in premarket trading, and the company has not identified who is responsible, in a year […]This story continues at The Next Web